Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Stock Split(Update)

16 Mar 2018 07:10

RNS Number : 9497H
Samsung Electronics Co. Ld
16 March 2018
 

Decision on Stock Split (Update)

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("Samsung") today announced that the details of its stock split plan have been finalized. The stock split was originally announced on January 31, 2018. The updated details are set forth below:

 

 Information on decision regarding stock split

1. Details of Stock Split

Classification

Before Stock Split

After Stock Split

Face Value per Share (KRW)

5,000

100

Total Number of Shares Outstanding

Common Shares

128,386,494

6,419,324,700

Different Classes of Shares

18,072,580

903,629,000

2. Stock Split Schedule

Scheduled Date of Shareholders' Meeting

March 23, 2018

Period for Tendering Existing Shares

From

March 26, 2018

To

May 2, 2018 (originally April 26)

Scheduled Period of Trading Suspension

Three business days covering April 30 and May 2-3, 2018 as May 1 is a non-trading day (originally from April 25 to the day before scheduled listing date of new share certificates)

Period for Closing Shareholders' Registry

From

May 3, 2018 (originally April 27)

To

May 10, 2018 (originally May 14)

Scheduled Listing Date of New Share Certificates

May 4, 2018 (originally May 16)

3. Purpose of Stock Split

To increase the number of shares outstanding

4. Other important matters related to investment decision

1. This plan will be submitted to the upcoming meeting of shareholders scheduled on March 23, 2018.

2. The total number of shares outstanding reflects the number of shares that were cancelled on January 30, 2018 (712,000 common shares and 178,000 preferred shares).

3. The above schedules are subject to change in accordance with the voting results at the shareholder meeting.

4. The different classes of shares refers to preferred shares, and details are as follows:

1) Preferred shares have no voting rights.

2) Preferred shares are non-cumulative and pay 1% higher cash dividend per annum than do common shares, based on face value.

3) In the event of stock dividends or a capital increase with or without consideration, the conditions as stipulated in Article 8 of Samsung Electronics' Articles of Incorporation shall apply to newly issued preferred shares.

5. The Scheduled Period of Trading Suspension excludes the scheduled date of Samsung's first quarter earnings release (April 26) and the expiry dates of futures and options (May 10 and May 15, respectively) to minimize market impacts and for investor convenience.

6. The procedure of change listing shall take place before the issuance of new shares. Registered shareholders who deposited their shares to the Korea Securities Depository (KSD) through a brokerage firm can start transactions from May 4, 2018, the scheduled listing date of new share certificates, and holders of stock certificates can start transactions from May 11, 2018.

7. Holders of stock certificates can start transactions on the date of new share certificates if they deposit their shares to the KSD through a brokerage firm. (Contact your brokerage firm for inquiries related to deposit schedules or procedures.)

 

Other Information:

ž The above information is based on the laws of Korea and only applies to shares traded in the stock exchange of Korea.

Citibank, the depositary bank, will provide a separate notice regarding information related to depository receipts.

ž Number of Independent Directors Present at the BOD Meeting: 5

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJFMRTMBMBMFP
Date   Source Headline
29th Aug 20258:57 amRNS2025 Half-year Business Report
31st Jul 20259:49 amRNSReport on Share Disposition Results
31st Jul 20259:48 amRNSTransaction with Affilliate Company
31st Jul 20258:55 amRNSSingle Sale and Supply Contract - Replacement
31st Jul 20257:00 amRNSQuarterly Dividend for Second Quarter 2025
31st Jul 20257:00 amRNS2025 2Q Earnings Release
28th Jul 20259:19 amRNSSingle Sale and Supply Contract
25th Jul 20259:53 amRNSDecision on Share Disposition
8th Jul 20258:11 amRNSDecision on Share Repurchase
8th Jul 20257:15 amRNSNotice of 2Q 2025 Earning Release schedule
8th Jul 20257:09 amRNS2Q 2025 Pre-Earnings Guidance
27th Jun 20258:51 amRNSSustainability Report 2025
30th May 20259:58 amRNSCorporate Governance Report FY2024
30th May 20259:49 amRNS2025 1Q Interim Business Report
28th May 202510:10 amRNSReport on Share Disposition Results
23rd May 20259:36 amRNSDecision on Share Disposition
16th May 20259:34 amRNSReport on Share Repurchase Results
30th Apr 20259:05 amRNS2024 Business Report
30th Apr 20258:45 amRNSCharitable Contribution
30th Apr 20258:42 amRNSTransactions with Affiliated Companies
30th Apr 20257:00 amRNS2025 1Q Earnings Release
30th Apr 20257:00 amRNSQuarterly Dividend for First Quarter 2025
8th Apr 20257:00 amRNSNotice of 1Q 2025 Earning Release schedule
8th Apr 20257:00 amRNS1Q 2025 Pre-Earnings Guidance
26th Mar 20257:00 amRNSNotice on Change of Chief Executive Officer
19th Mar 20258:16 amRNSAppointment of New Chief Executive Officer
19th Mar 20258:11 amRNSResults of the 56th Annual General Meeting
18th Feb 202510:21 amRNSDecision on Share Repurchase
18th Feb 202510:07 amRNSCharitable Contribution
18th Feb 20259:57 amRNSDecision on Cancellation of Shares
18th Feb 20259:14 amRNSReference Material for 2025 AGM
18th Feb 20259:01 amRNS2024 Separate Financial Statements
18th Feb 20258:58 amRNS2024 Consolidated Financial Statements
17th Feb 202512:16 pmRNSReport on Share Repurchase Results
13th Feb 20259:12 amRNSFinal Delisting and Listing of Stocks
13th Feb 20258:42 amRNSAdmission to Trading
10th Feb 202512:05 pmRNSNotice of Approval and Publication of Prospectus
31st Jan 20257:00 amRNS2024 4Q Earning Release
31st Jan 20257:00 amRNSYear-End Dividend for FY2024
31st Jan 20257:00 amRNSAnnouncement of Capex Result for FY2024
8th Jan 20257:00 amRNS4Q 2024 Pre-Earnings Guidance
8th Jan 20257:00 amRNSNotice of 4Q 2024 Earning Release
23rd Dec 20247:00 amRNSInvestment in New Semiconductor Plant in Texas, US
29th Nov 20248:01 amRNSCharitable Contribution
29th Nov 20247:55 amRNS2024 3Q Interim Business Report
29th Nov 20247:41 amRNSTransaction with Affiliate Company
26th Nov 202410:01 amRNSDelisting of GDR from the LuxembourgStockExchange
18th Nov 20249:22 amRNSDecision on Share Repurchase Plan
4th Nov 202410:05 amRNSDelisting Announcement
31st Oct 20249:14 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.